About the Company
PetMedix is using the highest quality science to make the medicines our pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human therapeutic drug development, we are applying the cutting edge of science to bring breakthroughs for the animals we love and care for.
The bond we have with our dogs and cats is a special one, they share our homes and are such an important part of our lives. Unfortunately, they also share our health problems, and can suffer from many of the same diseases and conditions we do. Whilst it is possible to give some types of human medicines to pets, it is not possible to do it with therapeutic antibodies – the pet immune systems would reject them. What this means is that there are all of these conditions, such as cancer, allergy, arthritis, and many more, that we can successfully treat in people but where our pets are suffering needlessly.
PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that can develop fully species-specific, naturally-generated therapeutic antibodies. We will use these platforms to develop our own veterinary medicines to target some of the most important underserved clinical areas, which not only would have critical healthcare impact, but also represent excellent market opportunities.
PetMedix are proud to have been voted ‘Best Start-Up 2019’ in the Animal Pharm Awards and ‘One to Watch’ in the Nature Spinoff Awards 2020.